ELIXIR PHARMACEUTICALS, INC.
🏢 View company profile →6Patents
4Active
6Granted
38Portfolio score
Filing activity: Dec 15, 2003 → Jul 10, 2009 · 4 expiring within 5 years
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US8486990B2 | SirT inhibitors that bind to NAD | Chemistry; Metallurgy | 7 | Active |
| US7829589B2 | Sulfonamide compounds and uses thereof | Chemistry; Metallurgy | 7 | Active |
| US7504506B2 | Therapeutic compounds and uses thereof | Chemistry; Metallurgy | 1 | Expired |
| US7575883B2 | Cytochrome c acetylation | Physics | 0 | Expired |
| US7771961B2 | Cytochrome c acetylation | Physics | 0 | Active |
| US7897765B2 | Therapeutic compounds and uses thereof | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.